The Protein Journal

, Volume 29, Issue 5, pp 306–313 | Cite as

Molecular Characterization of the Camelus dromedarius Putative Cytochrome P450s Genes

  • Mohammad Saud Alanazi
  • Hesham Mahmoud Saeed
  • Farid Shokry Ataya
  • Mohammad Dawoud Bazzi
Article

Abstract

The expression levels of cytochrome P450s were examined in different camel tissues by western blotting and semi-quantitative polymerase chain reaction. Camelus dromedarius liver microsomes were found to express different P450s isoenzymes constitutively. The maximum expression of P450 protein was seen in the camel liver in the order of P450 2E1, 1A1, 3A and 2B1/2. Camel extrahepatic tissues, kidney, spleen and the lung showed detectable levels of P450s 1A1 but lower than that noticed in liver. Detectable level of P450 2B1/2 was also observed in camel lung (29.5 vs. 58% liver microsomes). P450scc and 21-hydroxylase were found to be differentially expressed only in camel testis. Partial sequences of these P450s genes showed high similarities with the human P450s. These results demonstrate that the multiple forms of P450s are differentially expressed in camel tissues and that the relative levels of expression are comparable with other mammals. These observations might be important in understanding the differential susceptibility of camel tissues to the toxic effects of xenobiotics and environmental pollution.

Keywords

Monooxygenases Xenobiotics Degenerate primers Semi-quantitatve PCR Western blotting Camelus dromedarius 

Abbreviations

AHR-ARNT

Arylhydrocarbon receptor-arylreceptor nuclear translocator

P450

Cytochrome P450

P450scc

Cytochrome P450 side chain cholesterol cleavage

PAHs

Polychlorinated aliphatic hydrocarbons

PCDDs

Polychlorinated dibenzo-ρ-dioxins

Notes

Acknowledgments

This study was supported totally by the Genome Research Unit, Department of Biochemistry, KSU.

References

  1. 1.
    Bradford MM (1976) Anal Biochem 72:248–254CrossRefGoogle Scholar
  2. 2.
    Darwish WS, Morshdy AE, Ikenaka Y, Ibrahim ZS, Fujita S, Ishizuka M (2010) J Vet Med Sci 72:221–224CrossRefGoogle Scholar
  3. 3.
    Diliberto JJ, Burgin D, Birnbaum LS (1997) Biochem Biophys Res Commun 236:431–433CrossRefGoogle Scholar
  4. 4.
    Doherty MM, Michael M (2003) Curr Drug Metabol 4:131–149CrossRefGoogle Scholar
  5. 5.
    El Sheikh HA, Ali BH, Homeida AM, Hapke HJ (1991) Comp Biochem Physiol C 98:293–297CrossRefGoogle Scholar
  6. 6.
    Elskus AA, Monosson E, McElroy AE, Stegeman JJ, Woltering DS (1999) Aquat Toxicol 45:99–113CrossRefGoogle Scholar
  7. 7.
    Guengerich FP (2001) Chem Res Toxicol 14:611–650CrossRefGoogle Scholar
  8. 8.
    Hasler JA, Estabrook R, Murray M, Pikuleva I, Waterman M, Capdevila J, Holla V, Helvig C, Falck JR, Farrell G, Kaminsky LS, Spivack SD, Boitier E, Beaune P (1999) Mol Aspect Med 20:1–137CrossRefGoogle Scholar
  9. 9.
    Laemmli UK (1970) Nature 227:680–685CrossRefGoogle Scholar
  10. 10.
    Leclerc J, Tournel G, Courcot E, Pottier N, Lafitte JJ, Jaillard S, Mensier E, Lhermitte M, Broly F, Lo-Guidice JM (2010) Biochimie 92:292–306CrossRefGoogle Scholar
  11. 11.
    Lieber CS (1997) Physiol Rev 77:517–544Google Scholar
  12. 12.
    McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN (1990) J Natl Cancer Inst 82:1333–1339CrossRefGoogle Scholar
  13. 13.
    Morris DL, Davila JC (1996) Biochem Pharmacol 52:781–792CrossRefGoogle Scholar
  14. 14.
    Murtomaa M, Viitala P, Hokkanen J, Pelkonen O, Rautio A (2010) Environ Toxicol Pharmacol 29:19–23CrossRefGoogle Scholar
  15. 15.
    Nebbia C, Dacasto M, Rossetto A, Giuliano A, Carletti M (2003) Vet J 165:53–64CrossRefGoogle Scholar
  16. 16.
    Nebert DW, Dalton TP (2006) Nat Rev 6:947–960Google Scholar
  17. 17.
    Nebert DW, Puga A, Vasiliou V (1993) Ann N Y Acad Sci 685:624–640CrossRefGoogle Scholar
  18. 18.
    Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW (2004) Pharmacogenetics 14:1–18CrossRefGoogle Scholar
  19. 19.
    Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) Pharmacogenetics 6:1–42CrossRefGoogle Scholar
  20. 20.
    Raza H, Bhagwat SV, John A (2004) Comp Biochem Physiol C Toxicol Pharmacol 139:289–293CrossRefGoogle Scholar
  21. 21.
    Raza H, John A, Lakhani MS, Ahmed I, Montague W (1998) Comp Biochem Physiol 121:205–211Google Scholar
  22. 22.
    Raza H, Montague W (1993) Comp Biochem Physiol C 104:137–145CrossRefGoogle Scholar
  23. 23.
    Raza H, Montague W (1994) Comp Biochem Physiol Pharmacol Toxicol Endocrinol 107:379–386CrossRefGoogle Scholar
  24. 24.
    Sambrook J, Fritsch E, Manaiatis T (1989) Molecular cloning: a laboratory manual 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
  25. 25.
    Sanger F, Nicklen S, Coulson AR (1977) Proc Natl Acad Sci USA 74:5463–5467CrossRefGoogle Scholar
  26. 26.
    Seliskar M, Rozman D (2007) Biochim Biophys Acta 1770:458–466Google Scholar
  27. 27.
    Towbin H, Staehelin T, Gordon J (1979) Proc Natl Acad Sci USA 76:4350–4354CrossRefGoogle Scholar
  28. 28.
    Uppstad H, Ovrebo S, Haugen A, Mollerup S (2010) Toxicol Lett 192:221–228CrossRefGoogle Scholar
  29. 29.
    Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T (1992) Carcinogenesis 13:1789–1794CrossRefGoogle Scholar
  30. 30.
    Yuan PM, Ryan DE, Levin W, Shively JE (1983) Proc Natl Acad Sci USA 80:1169–1173CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Mohammad Saud Alanazi
    • 1
  • Hesham Mahmoud Saeed
    • 1
  • Farid Shokry Ataya
    • 1
  • Mohammad Dawoud Bazzi
    • 1
  1. 1.Genome Research Chair, Biochemistry Department, Faculty of ScienceKing Saud UniversityRiyadhKingdom of Saudi Arabia

Personalised recommendations